Studying metabolism and hormones in women with polycystic ovary syndrome
Observes hormones, body makeup and bone health in women with polycystic ovary syndrome.
Plain-language title generated from the registry record
Registry title: Characterization of a Prospective Cohort of Women With PCOS
Key facts
- Where
- Odense, DenmarkSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18 to 45 with polycystic ovary syndrome (PCOS).
- Age
- 18 Years to 45 Years
- Sex
- Women only
- Disease stage
- Polycystic ovary syndrome (PCOS)
Main reasons for not taking part
- Pregnancy
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT02010814, who can take part
Where in Denmark
- Department of Endocrinology, Odense University HospitalOdense, DenmarkContact: Dorte Glintborg, MD PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Odense University Hospital
- Trial code
- NCT02010814
- Record updated
- 25 April 2023
- Original description
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. PCOS is characterized by increase levels of testosterone, unwanted hair growth, adiposity, irregular menstrual cycle, and infertility. PCOS is associated with diabetes mellitus and cardiovascular diseases. Women with PCOS are reported to have increased levels of stress hormones, which may be associated with decreased quality of life. Increased testosterone levels in women may decrease the risk of osteoporosis. The aim of the present study is to measure levels of stress hormones in urine and describe quality of life using questionnaires. In addition we aim to characterize body composition and bone architecture using DXA and ExtremeCT.Read full original descriptionShow less
Metabolic and Endocrinological Characterization of a Prospective Cohort of Women With PCOS
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. PCOS is characterized by increase levels of testosterone, unwanted hair growth, adiposity, irregular menstrual cycle, and infertility. PCOS is associated with diabetes mellitus and cardiovascular diseases. Women with PCOS are reported to have increased levels of stress hormones, which may be associated with decreased quality of life. Increased testosterone levels in women may decrease the risk of osteoporosis. The aim of the present study is to measure levels of stress hormones in urine and describe quality of life using questionnaires. In addition we aim to characterize body composition and bone architecture using DXA and ExtremeCT.
As part of the project, a Biobank with fasting blood samples from participants is established.
Inclusion: PCOS.
Exclusion: pregnancy.